🇺🇸 FDA
Patent

US 12195724

Methods of producing T cell populations enriched for stable regulatory T-cells

granted A61KA61K2035/124A61K35/17

Quick answer

US patent 12195724 (Methods of producing T cell populations enriched for stable regulatory T-cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2035/124, A61K35/17